The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
A listing of human tumor antigens recognized by T cells: March 2004 update
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
Chen, Y.-T., Scanlan, M. J., Sahin, U., Türeci, Ö., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M., & Old, L. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1914 · Cited by 1,247
A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3515 · Cited by 1,092
Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6458 · Cited by 914
Coulie, P. G., Brichard, V, Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.35 · Cited by 903
Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., & Rosenberg, S. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.347 · Cited by 862
Human tumor antigens recognized by T lymphocytes.
Boon, T., & van der Bruggen, P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.725 · Cited by 842
Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines
Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., & Slingluff, C. L. (1994) · Science · doi:10.1126/science.7513441 · Cited by 824
Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F., & Boon, T. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.921 · Cited by 762
Ikeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J.-F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80426-4 · Cited by 762
Jäger, E., Chen, Y.-T., Drijfhout, J. W., Karbach, J., Ringhoffer, M., Jäger, D., Arand, M., Wada, H., Noguchi, Y., Stockert, E., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.265 · Cited by 725
Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., & Boon, T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1453 · Cited by 679
De Smet, C., Lurquin, C., Lethé, B., Martelange, V., & Boon, T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7327 · Cited by 598
Structure, chromosomal localization, and expression of 12 genes of the MAGE family
De Plaen, E., Traversari, C., Gaforio, J. J., Szikora, J.-P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethé, B., Lurquin, C., Chomez, P., et al. (1994) · Immunogenetics · doi:10.1007/bf01246677 · Cited by 586
BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
Boël, P., Wildmann, C., Sensi, M. L., Brasseur, R., Renauld, J.-C., Coulie, P., Boon, T., & van der Bruggen, P. (1995) · Immunity · doi:10.1016/s1074-7613(95)80053-0 · Cited by 583
Vonderheide, R. H., Hahn, W. C., Schultze, J. L., & Nadler, L. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80066-7 · Cited by 570
Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., & Boon, T. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.689 · Cited by 567
Robbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E., & Rosenberg, S. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1185 · Cited by 550
Fisk, B., Blevins, T. L., Wharton, J. T., & Ioannides, C. G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.6.2109 · Cited by 543
Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., & Rosenberg, S. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3961 · Cited by 540
Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands
Wang, H. Y., Lee, D. A., Peng, G., Guo, Z., Li, Y., Kiniwa, Y., Shevach, E. M., & Wang, R.-F. (2004) · Immunity · doi:10.1016/s1074-7613(03)00359-5 · Cited by 515
Tsang, K. Y., Zaremba, S., Nieroda, C. A., Zhu, M. Z., Hamilton, J. M., & Schlom, J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.13.982 · Cited by 498
Peoples, G. E., Goedegebuure, P. S., Smith, R., Linehan, D. C., Yoshino, I., & Eberlein, T. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.432 · Cited by 439
Coulie, P. G., Lehmann, F., Lethé, B., Herman, J., Lurquin, C., Andrawiss, M., & Boon, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7976 · Cited by 423
Morel, S., Lévy, F., Burlet-Schiltz, O., Brasseur, F., Probst-Kepper, M., Peitrequin, A.-L., Monsarrat, B., Van Velthoven, R., Cerottini, J.-C., Boon, T., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80163-6 · Cited by 415
ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
Vucic, D., Stennicke, H. R., Pisabarro, M. T., Salvesen, G. S., & Dixit, V. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00781-8 · Cited by 414
Two tyrosinase nonapeptides recognized on HLA‐A2 melanomas by autologous cytolytic T lymphocytes
Wölfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Zum Büschenfelde, K. M., & Boon, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240340 · Cited by 411
Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?
Parmiani, G., Castelli, C., Dalerba, P., Mortarini, R., Rivoltini, L., Marincola, F. M., & Anichini, A. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.805 · Cited by 401
Self-citationBelli, F., Testori, A., Rivoltini, L., Maio, M., Andreola, G., Sertoli, M. R., Gallino, G., Piris, A., Cattelan, A., Lazzari, I., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.134 · Cited by 387
Self-citationTumor‐specific shared antigenic peptides recognized by human T cells
Van Der Bruggen, P., Zhang, Y., Chaux, P., Stroobant, V., Panichelli, C., Schultz, E. S., Chapiro, J., Van den Eynde, B. J., Brasseur, F., & Boon, T. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18806.x · Cited by 378
van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boël, P., De Smet, C., Traversari, C., Townsend, A., & Boon, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241218 · Cited by 367
Ohminami, H., Yasukawa, M., & Fujita, S. (2000) · Blood · doi:10.1182/blood.v95.1.286 · Cited by 347
Immune recognition of a human renal cancer antigen through post-translational protein splicing
Hanada, K.-I., Yewdell, J. W., & Yang, J. C. (2004) · Nature · doi:10.1038/nature02240 · Cited by 336
A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck Carcinoma
Mandruzzato, S., Brasseur, F., Andry, G., Boon, T., & Bruggen, P. V. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.785 · Cited by 321
Brossart, P., Heinrich, K. S., Stuhler, G., Behnke, L., Reichardt, V. L., Stevanovic, S., Muhm, A., Rammensee, H.-G., Kanz, L., & Brugger, W. (1999) · Blood · doi:10.1182/blood.v93.12.4309 · Cited by 306
Cloning Genes Encoding MHC Class II-Restricted Antigens: Mutated CDC27 as a Tumor Antigen
Wang, R.-F., Wang, X., Atwood, A. C., Topalian, S. L., & Rosenberg, S. A. (1999) · Science · doi:10.1126/science.284.5418.1351 · Cited by 300
Topalian, S. L., Rivoltini, L., Mancini, M., Markus, N. R., Robbins, P. F., Kawakami, Y., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9461 · Cited by 286
Schmidt, S. M., Schag, K., Müller, M. R., Weck, M. M., Appel, S., Kanz, L., Grünebach, F., & Brossart, P. (2003) · Blood · doi:10.1182/blood-2002-08-2554 · Cited by 277
Sæterdal, I., Bjørheim, J., Lislerud, K., Gjertsen, M. K., Bukholm, I. K., Olsen, O. C., Nesland, J. M., Eriksen, J. A., Møller, M., Lindblom, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231326898 · Cited by 273
Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T Lymphocytes
Wang, R.-F., Appella, E., Kawakami, Y., Kang, X., & Rosenberg, S. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2207 · Cited by 272
Correale, P., Nieroda, C., Zaremba, S., Zhu, M., Schlom, J., Tsang, K. Y., & Konstantin, W. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.4.293 · Cited by 264
Kessler, J. H., Beekman, N. J., Bres-Vloemans, S. A., Verdijk, P., van Veelen, P. A., Kloosterman-Joosten, A. M., Vissers, D. C. J., ten Bosch, G. J. A., Kester, M. G. D., Sijts, A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.1.73 · Cited by 263
Andersen, M. H., Pedersen, L. Ø., Becker, J. C., & Straten, P. T. (2001) · PubMed · Cited by 258
Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.
Topalian, S. L., Gonzales, M. I., Parkhurst, M., Li, Y. F., Southwood, S., Sette, A., Rosenberg, S. A., & Robbins, P. F. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.1965 · Cited by 257
Andersen, M. H., Pedersen, L. Ø., Capeller, B., Bröcker, E. B., Becker, J. C., & Straten, P. T. (2001) · PubMed · Cited by 255
Cytotoxic T cell immunity against telomerase reverse transcriptase in humans
Minev, B., Hipp, J., Firat, H., Schmidt, J. D., Langlade-Demoyen, P., & Zanetti, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070560797 · Cited by 255
Wang, R. F., Parkhurst, M. R., Kawakami, Y., Robbins, P. F., & Rosenberg, S. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1131 · Cited by 255
Oka, Y., Elisseeva, O. A., Tsuboi, A., Ogawa, H., Tamaki, H., Li, H., Oji, Y., Kim, E. H., Soma, T., Asada, M., et al. (2000) · Immunogenetics · doi:10.1007/s002510050018 · Cited by 245
Schmitz, M., Diestelkoetter, P., Weigle, B., Schmachtenberg, F., Stevanović, S., Ockert, D., Rammensee, H., & Rieber, E. P. (2000) · PubMed · Cited by 243
Yotnda, P., Firat, H., Garcia-Pons, F., Garcia, Z., Gourru, G., Vernant, J. P., Lemonnier, F. A., Leblond, V, & Langlade-Demoyen, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci488 · Cited by 238
Frameshift peptide-derived T-cell epitopes: A source of novel tumor-specific antigens
Linnebacher, M., Gebert, J., Rudy, W., Woerner, S., Yuan, Y. P., Bork, P., & von Knebel Doeberitz, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1298 · Cited by 234
Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+ T Lymphocytes
Chaux, P., Vantomme, V., Stroobant, V., Thielemans, K., Corthals, J., Luiten, R., Eggermont, A. M. M., Boon, T., & van der Bruggen, P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.767 · Cited by 234
Guilloux, Y., Lucas, S., Brichard, V. G., Van Pel, A., Viret, C., De Plaen, E., Brasseur, F., Lethé, B., Jotereau, F., & Boon, T. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1173 · Cited by 230
Jäger, E., Jäger, D., Karbach, J., Chen, Y.-T., Ritter, G., Nagata, Y., Gnjatic, S., Stockert, E., Arand, M., Old, L. J., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.625 · Cited by 229
Bruggen, P. V. D., Szikora, J., Boël, P., Wildmann, C., Somville, M., Sensi, M., & Boon, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240930 · Cited by 228
Shichijo, S., Nakao, M., Imai, Y., Takasu, H., Kawamoto, M., Niiya, F., Yang, D., Toh, Y., Yamana, H., & Itoh, K. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.3.277 · Cited by 214
Wang, R.-F., Johnston, S. L., Zeng, G., Topalian, S. L., Schwartzentruber, D. J., & Rosenberg, S. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3596 · Cited by 204
Parkhurst, M. R., Fitzgerald, E., Southwood, S., Sette, A., Rosenberg, S. A., & Kawakami, Y. (1998) · PubMed · Cited by 192
Integrated functional genomics approach for the design of patient-individual antitumor vaccines.
Weinschenk, T., Gouttefangeas, C., Schirle, M., Obermayr, F., Walter, S., Schoor, O., Kurek, R., Loeser, W., Bichler, K., Wernet, D., et al. (2002) · PubMed · Cited by 190
Cancer/testis (CT) antigens - a new link between gametogenesis and cancer.
Old, L. J. (2001) · PubMed · Cited by 190
An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.
Hirohashi, Y., Torigoe, T., Maeda, A., Nabeta, Y., Kamiguchi, K., Sato, T., Yoda, J., Ikeda, H., Hirata, K., Yamanaka, N., et al. (2002) · PubMed · Cited by 187
Baren, V., Chambost, Ferrant, Michaux, Ikeda, Millard, Olive, Boon, & Coulie (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00982.x · Cited by 183
Tsai, V, Southwood, S., Sidney, J., Sakaguchi, K., Kawakami, Y., Appella, E., Sette, A., & Celis, E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1796 · Cited by 175
Ashhab, Y., Alian, A., Polliack, A., Panet, A., & Yehuda, D. B. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02366-3 · Cited by 173
Rongcun, Y., Salazar-Onfray, F., Charo, J., Malmberg, K.-J., Evrin, K., Maes, H., Kono, K., Hising, C., Petersson, M., Larsson, O., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.1037 · Cited by 173
Gazzaniga, P., Gradilone, A., Giuliani, L., Gandini, O., Silvestri, I., Nofroni, I., Saccani, G., Frati, L., & Aglianò, A. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg002 · Cited by 173
Characterization of the GAGE genes that are expressed in various human cancers and in normal testis.
Backer, O. D., Arden, K. C., Boretti, M., Vantomme, V., Smet, C. D., Czekay, S., Viars, C. S., Plaen, E. D., Brasseur, F., Chomez, P., et al. (1999) · PubMed · Cited by 167
Yang, D., Nakao, M., Shichijo, S., Sasatomi, T., Takasu, H., Matsumoto, H., Mori, K., Hayashi, A., Yamana, H., Shirouzu, K., et al. (1999) · PubMed · Cited by 163
Zarour, H. M., Kirkwood, J. M., Kierstead, L. S., Herr, W., Brusić, V., Slingluff, C. L., Sidney, J., Sette, A., & Storkus, W. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.400 · Cited by 162
Gjertsen, M. K., Bjørheim, J., Saeterdal, I., Myklebust, J., & Gaudernack, G. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970904)72:5<784::aid-ijc14>3.0.co;2-9 · Cited by 161
Chaux, P., Luiten, R. M., Demotte, N., Vantomme, V., Stroobant, V., Traversari, C., Russo, V. E. A., Schultz, E. S., Cornelis, G. R., Boon, T., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2928 · Cited by 156
Doménech, N., Henderson, R. A., & Finn, O. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.4766 · Cited by 155
Identification of CD4+ T Cell Epitopes from NY-ESO-1 Presented by HLA-DR Molecules
Zeng, G., Touloukian, C. E., Wang, X., Restifo, N. P., Rosenberg, S. A., & Wang, R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.1153 · Cited by 151
Russo, V. E. A., Tanzarella, S., Dalerba, P. D., Rigatti, D., Rovere, P. Q., Villa, A., Bordignon, C., & Traversari, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040540197 · Cited by 146
Lupetti, R., Pisarra, P., Verrecchia, A., Farina, C., Nicolini, G., Anichini, A., Bordignon, C., Sensi, M., Parmiani, G., & Traversari, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1005 · Cited by 146
Self-citationSequence and expression pattern of the human MAGE2 gene
Smet, C. D., Lurquin, C., van der Bruggen, P., Plaen, E. D., Brasseur, F., & Boon, T. (1994) · Immunogenetics · doi:10.1007/bf00188615 · Cited by 145
Brändle, D., Brasseur, F., Weynants, P., Boon, T., & den Eynde, B. J. V. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2501 · Cited by 144
Wang, R., Wang, X., & Rosenberg, S. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.10.1659 · Cited by 143
Gambacorti-Passerini, C. B., Grignani, F., Arienti, F., Pandolfi, P. P., Pelicci, P. G., & Parmiani, G. (1993) · Blood · doi:10.1182/blood.v81.5.1369.1369 · Cited by 140
Self-citationRobbins, P. F., El‐Gamil, M., Li, Y. F., Topalian, S. L., Rivoltini, L., Sakaguchi, K., Appella, E., Kawakami, Y., & Rosenberg, S. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.11.5944 · Cited by 140
Scanlan, M. J., Altorki, N. K., Gure, A. O., Williamson, B., Jungbluth, A. A., Chen., Y., & Old, L. J. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00385-7 · Cited by 140
Identification on a human sarcoma of two new genes with tumor-specific expression.
Martelange, V., Smet, C. D., Plaen, E. D., Lurquin, C., & Boon, T. (2000) · Cancer Research · Cited by 139
Lurquin, C., Smet, C. D., Brasseur, F., Muscatelli, F., Martelange, V., Plaen, E. D., Brasseur, R., Monaco, A. P., & Boon, T. (1997) · Genomics · doi:10.1006/geno.1997.5052 · Cited by 139
Nagorsen, D., Keilholz, U., Rivoltini, L., Schmittel, A. H., Letsch, A., Asemissen, A. M., Berger, G., Buhr, H. J., Thiel, E., & Scheibenbogen, C. (2000) · PubMed · Cited by 137
Human tumor antigens recognized by T-cells
Kawakami, Y., & Rosenberg, S. A. (1997) · Immunologic Research · doi:10.1007/bf02786397 · Cited by 136
den Eynde, B. J. V., Gaugler, B., Probst‐Kepper, M., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1793 · Cited by 134
Vissers, J. L. M., de Vries, I. J. M., Schreurs, M. W. J., Engelen, L. P. H., Oosterwijk, E., Figdor, C. G., & Adema, G. J. (1999) · PubMed · Cited by 134
Robbins, P. F., El‐Gamil, M., Li, Y. F., Fitzgerald, E., Kawakami, Y., & Rosenberg, S. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.303 · Cited by 133
Kittlesen, D. J., Thompson, L. W., Gulden, P. H., Skipper, J., Colella, T. A., Shabanowitz, J., Hunt, D. F., Engelhard, V. H., & Slingluff, C. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2099 · Cited by 132
Echchakir, H., Mami‐Chouaib, F., Vergnon, I., Baurain, J., Karanikas, V., Chouaïb, S., & Coulie, P. G. (2001) · PubMed · Cited by 132
Brichard, V. G., Herman, J., Pel, A. V., Wildmann, C., Gaugler, B., Wölfel, T., Boon, T., & Lethé, B. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260135 · Cited by 131
Identification of a Gene Coding for a New Squamous Cell Carcinoma Antigen Recognized by the CTL
Nakao, M., Shichijo, S., Imaizumi, T., Inoue, Y., Matsunaga, K., Yamada, A., Kikuchi, M., Tsuda, N., Ohta, K., Takamori, S., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2565 · Cited by 131
Kawashima, I., Tsai, V., Southwood, S., Takesako, K., Sette, A., & Celis, E. (1999) · PubMed · Cited by 127
Okano, F., Storkus, W. J., Chambers, W. H., Pollack, I. F., & Okada, H. (2002) · PubMed · Cited by 123
Lucas, S., Plaen, E. D., & Boon, T. (2000) · International Journal of Cancer · Cited by 122
Ayyoub, M., Stevanović, S., Şahin, U., Guillaume, P., Servis, C., Rimoldi, D., Valmori, D., Romero, P. J., Cerottini, J., Rammensee, H., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1717 · Cited by 121
Gure, A. O., Stockert, E., Arden, K. C., Boyer, A. D., Viars, C. S., Scanlan, M. J., Old, L. J., & Chen, Y. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000301)85:5<726::aid-ijc21>3.0.co;2-f · Cited by 121
Karanikas, V., Colau, D., Baurain, J., Chiari, R., Thonnard, J., Gutierrez-Roelens, I., Goffinet, C., SCHAFTINGEN, E. V., Weynants, P., Boon, T., et al. (2001) · PubMed · Cited by 119
Vonderheide, R. H., Anderson, K. S., Hahn, W. C., Butler, M. O., Schultze, J. L., & Nadler, L. M. (2001) · PubMed · Cited by 118
Chiari, R., Hames, G., Stroobant, V., Texier, C., Maillère, B., Boon, T., & Coulie, P. G. (2000) · PubMed · Cited by 117
Kawakami, Y., Robbins, P. F., Wang, X., Tupesis, J. P., Parkhurst, M. R., Kang, X., Sakaguchi, K., Appella, E., & Rosenberg, S. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6985 · Cited by 115
Yotnda, P., Garcia, F., Peuchmaur, M. M., Grandchamp, B., Duval, M., Lemonnier, F. A., VILMER, E., & Langlade‐Demoyen, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3126 · Cited by 111
Ronsin, C., Chung-Scott, V., Poullion, I., Aknouche, N., Gaudin, C., & Triebel, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.483 · Cited by 109
Wang, R., Johnston, S. L., Southwood, S., Sette, A., & Rosenberg, S. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.890 · Cited by 105
Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction
Schmollinger, J. C., Vonderheide, R. H., Hoar, K. M., Maecker‐Kolhoff, B., Schultze, J. L., Hodi, F. S., Soiffer, R. J., Jung, K., Kuroda, M. J., Letvin, N. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530311100 · Cited by 105
Herman, J., van der Bruggen, P., Luescher, I. F., Mandruzzato, S., Romero, P. J., Thonnard, J., Fleischhauer, K., Boon, T., & Coulie, P. G. (1996) · Immunogenetics · doi:10.1007/bf02199806 · Cited by 104
Consogno, G., Manici, S., Facchinetti, V., Bachi, A., Hammer, J., Conti‐Fine, B. M., Rugarli, C., Traversari, C., & Protti, M. P. (2003) · Blood · doi:10.1182/blood-2002-03-0933 · Cited by 103
Aarnoudse, C. A., van den Doel, P. B., Heemskerk, B., & Schrier, P. I. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990730)82:3<442::aid-ijc19>3.0.co;2-z · Cited by 102
Probst‐Kepper, M., Stroobant, V., Kridel, R., Gaugler, B., Landry, C., Brasseur, F., Cosyns, J., Weynand, B., Boon, T., & den Eynde, B. J. V. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.10.1189 · Cited by 102
Baurain, J., Colau, D., van Baren, N., Landry, C., Martelange, V., Vikkula, M., Boon, T., & Coulie, P. G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.6057 · Cited by 101
Passoni, L., Scardino, A., Bertazzoli, C., Gallo, B. M., Coluccia, A. M. L., Lemonnier, F. A., Kosmatopoulos, K., & Gambacorti-Passerini, C. B. (2002) · Blood · doi:10.1182/blood.v99.6.2100 · Cited by 101
Skipper, J., Kittlesen, D. J., Hendrickson, R. C., Deacon, D. H., Harthun, N. L., Wagner, S. N., Hunt, D. F., Engelhard, V. H., & Slingluff, C. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.5027 · Cited by 100
Zorn, E., & Hercend, T. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199902)29:02<592::aid-immu592>3.0.co;2-2 · Cited by 100
Casati, C., Dalerba, P. D., Rivoltini, L., Gallino, G., Deho, P., Rini, F., Belli, F., Mezzanzanica, D., Costa, A., Andreola, S. A., et al. (2003) · PubMed · Cited by 96
Self-citationLucas, S., Plaen, E. D., & Boon, T. (2000) · International Journal of Cancer · Cited by 96
Kono, K., Yang, R., Charo, J., Ichihara, F., Celis, E., Sette, A., Appella, E., Sekikawa, T., Matsumoto, Y., & Kiessling, R. W. (1998) · International Journal of Cancer · Cited by 93
Hogan, K. T., Eisinger, D. P., Cupp, S. B., Lekstrom, K. J., Deacon, D. H., Shabanowitz, J., Hunt, D. F., Engelhard, V. H., Slingluff, C. L., & Ross, M. M. (1998) · PubMed · Cited by 91
Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells.
Hiltbold, E. M., Ciborowski, P. S., & Finn, O. J. (1998) · PubMed · Cited by 90
A ras- Mutated Peptide Targeted by CTL Infiltrating a Human Melanoma Lesion
Linard, B., Bezieau, S., Benlalam, H., Labarrière, N., Guilloux, Y., Diez, E., & Jotereau, F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4802 · Cited by 88
Li, K., Adibzadeh, M., Halder, T. M., Kalbacher, H., Heinzel, S., Müller, C. A., Zeuthen, J., & Pawelec, G. (1998) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050501 · Cited by 82
Lucas, S., Brasseur, F., & Boon, T. (1999) · PubMed · Cited by 80
Chiari, R., Foury, F., Plaen, E. D., Baurain, J., Thonnard, J., & Coulie, P. G. (1999) · PubMed · Cited by 79
Khong, H. T., & Rosenberg, S. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.951 · Cited by 77
Cytolytic T Lymphocytes Recognize an Antigen Encoded by MAGE-A10 on a Human Melanoma
Huang, L.-Q., Brasseur, F., Serrano, A., Plaen, E. D., van der Bruggen, P., Boon, T., & Pel, A. V. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6849 · Cited by 77
Liu, G., Khong, H. T., Wheeler, C. J., Yu, J. S., Black, K. L., & Han, Y. (2003) · Journal of Immunotherapy · doi:10.1097/00002371-200307000-00002 · Cited by 75
Schmidt, S. M., Schag, K., Müller, M., Weinschenk, T., Appel, S., Schoor, O., Weck, M. M., Grünebach, F., Kanz, L., Stevanović, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2538 · Cited by 75
An Antigen Recognized by Autologous CTLs on a Human Bladder Carcinoma
Guéguen, M., Patard, J., Gaugler, B., Brasseur, F., Renauld, J., Cangh, P. J. V., Boon, T., & den Eynde, B. J. V. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.6188 · Cited by 72
A Processed Pseudogene Codes for a New Antigen Recognized by a Cd8+ T Cell Clone on Melanoma
Moreau‐Aubry, A., Guiner, S. L., Labarrière, N., Gesnel, M.-C., Jotereau, F., & Breathnach, R. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1617 · Cited by 72
Kobayashi, H., Kokubo, T., Takahashi, M., Sato, K., Miyokawa, N., Kimura, S., Kinouchi, R., & Katagiri, M. (1998) · Immunogenetics · doi:10.1007/s002510050375 · Cited by 70
Jaramillo, A., Majumder, K., Manna, P. P., Fleming, T. P., Doherty, G. M., DiPersio, J. F., & Mohanakumar, T. (2002) · International Journal of Cancer · doi:10.1002/ijc.10736 · Cited by 70
Kikuchi, M., Nakao, M., Inoue, Y., Matsunaga, K., Shichijo, S., Yamana, H., & Itoh, K. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990505)81:3<459::aid-ijc21>3.0.co;2-6 · Cited by 69
Rosenberg, S. A., Tong-On, P., Li, Y., Riley, J. P., El‐Gamil, M., Parkhurst, M. R., & Robbins, P. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2402 · Cited by 66
Tatsumi, T., Kierstead, L. S., Ranieri, E., Gesualdo, L., Schena, F. P., Finke, J. H., Bukowski, R. M., Brusić, V., Sidney, J., Sette, A., et al. (2003) · PubMed · Cited by 66
ten Bosch, G. J. A., Kessler, J. H., Joosten, A. M., Bres-Vloemans, A. A., Geluk, A., Godthelp, B. C., van Bergen, J., Melief, C. J. M., & Leeksma, O. (1999) · Blood · doi:10.1182/blood.v94.3.1038.415k22_1038_1045 · Cited by 63
A family of rapidly evolving genes from the sex reversal critical region in Xp21
Dabovic, B., Zanaria, E., Bardoni, B., Lisa, A., Bordignon, C., Russo, V. E. A., Matessi, C., Traversari, C., & Camerino, G. (1995) · Mammalian Genome · doi:10.1007/bf00352360 · Cited by 62
Dudley, M. E., & Roopenian, D. C. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.441 · Cited by 62
Panelli, M. C., Bettinotti, M. P., Lally, K. M., Ohnmacht, G. A., Li, Y., Robbins, P. F., Riker, A. I., Rosenberg, S. A., & Marincola, F. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4382 · Cited by 59
Campi, G., Crosti, M., Consogno, G., Facchinetti, V., Conti‐Fine, B. M., Longhi, R., Casorati, G., Dellabona, P., & Protti, M. P. (2003) · PubMed · Cited by 59
Lapointe, R., Royal, R. E., Reeves, M. E., Altomare, I. P., Robbins, P. F., & Hwu, P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4758 · Cited by 59
Azuma, T., Makita, M., Ninomiya, K., et al. (2002) · British Journal of Haematology · doi:10.1046/j.0007-1048.2001.03329.x · Cited by 58
Kawano, K., Gomi, S., Tanaka, K., Tsuda, N., Kamura, T., Itoh, K., & Yamada, A. (2000) · PubMed · Cited by 57
Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family.
Tanzarella, S., Russo, V. E. A., Lionello, I., Dalerba, P. D., Rigatti, D., Bordignon, C., & Traversari, C. (1999) · PubMed · Cited by 57
Slager, E. H., Borghi, M., van der Minne, C. E., Aarnoudse, C. A., Havenga, M. J. E., Schrier, P. I., Osanto, S., & Griffioen, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1490 · Cited by 57
Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.
Kobayashi, H., Omiya, R., Ruiz, M., Huarte, E., Sarobe, P., Lasarte, J. J., Herráiz, M., Sangro, B., Prìeto, J., Borrás‐Cuesta, F., et al. (2002) · PubMed · Cited by 56
EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes.
Alves, P. M. S., Faure, O., Graff‐Dubois, S., Gross, D., Cornet, S., Chouaı̈b, S., Miconnet, I., Lemonnier, F. A., & Kosmatopoulos, K. (2003) · PubMed · Cited by 55
Novellino, L., Renkvist, N., Rini, F., Mazzocchi, A., Rivoltini, L., Greco, A., Deho, P., Squarcina, P., Robbins, P. F., Parmiani, G., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6363 · Cited by 54
Self-citationUmano, Y., Tsunoda, T., Tanaka, H., Matsuda, K., Yamaue, H., & Tanimura, H. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1715 · Cited by 47
Ohminami, H., Yasukawa, M., Kaneko, S., Yakushijin, Y., Abe, Y., Kasahara, Y., Ishida, Y., & Fujita, S. (1999) · Blood · doi:10.1182/blood.v93.3.925 · Cited by 44
Identification of a Mutated Fibronectin As a Tumor Antigen Recognized by CD4+T Cells
Wang, H. Y., Zhou, J., Zhu, K., Riker, A. I., Marincola, F. M., & Wang, R. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020141 · Cited by 41
Khong, H. T., & Rosenberg, S. A. (2002) · PubMed · Cited by 40
Harada, M., Li, Y. F., El‐Gamil, M., Ohnmacht, G. A., Rosenberg, S. A., & Robbins, P. F. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200107000-00008 · Cited by 34
Identification of HLA-A*0201-restricted cytotoxic T lymphocyte epitope from TRAG-3 antigen.
Zhu, B., Chen, Z., Cheng, X., Lin, Z., Guo, J., Jia, Z., Zou, L., Wang, Z., Hu, Y., Wang, D., et al. (2003) · PubMed · Cited by 33
Yun, C., Senju, S., Fujita, H., Tsuji, Y., Irie, A., Matsushita, S., & Nishimura, Y. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.540206.x · Cited by 28
Ma, L., Moan, J. E., Peng, Q., & Iani, V. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981109)78:4<518::aid-ijc20>3.0.co;2-0 · Cited by 27
Vigneron, N., Ooms, A., Morel, S., Degiovanni, G., & den Eynde, B. J. V. (2002) · PubMed · Cited by 20
Pisarra, P., Lupetti, R., Anichini, A., Sensi, M., Palumbo, A., Napolitano, A., Prota, G., & Parmiani, G. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00023.x · Cited by 19
Self-citationOhkouchi, S., Kawamoto, N., Koga, M., Sakanashi, F., Shichijo, S., Saijo, Y., Nukiwa, T., Itoh, K., & Yamada, A. (2003) · European Journal of Immunology · doi:10.1002/eji.200324149 · Cited by 7
Cited by
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Hu, Z., Ott, P. A., & Wu, C. J. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.131 · Cited by 1,067
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Liu, J., Fu, M., Wang, M., Wan, D., Wei, Y., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01247-x · Cited by 715
Immunotherapy and chemotherapy — a practical partnership
Lake, R. A., & Robinson, B. W. S. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1613 · Cited by 646
Schumacher, T. N., Scheper, W., & Kvistborg, P. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053402 · Cited by 574
Metadata
- Authors
- Novellino, L., Castelli, C., & Parmiani, G.
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2004-08-07
- Volume
- 54
- Issue
- 3
- Pages
- 187-207
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- OpenAlex
- W2052892134
- Cited by
- 466
- References
- 158
- FWCI
- 14.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.